Search Results Search Sort by RelevanceMost Recent Medicine and Society Feb 2020 How Should Low- and Middle-Income Countries Motivate Equity in Cancer Prevention and Control? Justin M. List, MD, MAR, MSc and Jeremy M. O’Connor, MD, MHS Government and public-private coalitions have important roles in cancer surveillance in LMICs. AMA J Ethics. 2020;22(2):E147-155. doi: 10.1001/amajethics.2020.147. Case and Commentary Feb 2020 When Is a Suboptimal Approach to Cancer Screening Better Than None? Ramy Sedhom, MD and Bishal Gyawali, MD, PhD Mortality rates for breast cancer are higher where treatments are unavailable and unaffordable. Though less effective, breast examination could be a good screening approach. AMA J Ethics. 2020;22(2):E93-101. doi: 10.1001/amajethics.2020.93. Policy Forum Feb 2020 How Should Global Tobacco Control Efforts Be Prioritized to Protect Children in Resource-Poor Regions? Stella Aguinaga Bialous, DrPH and Yvette van der Eijk, PhD Tobacco and e-cigarette marketing is largely unrestricted in low- and middle-income countries, a violation of children’s rights. AMA J Ethics. 2020;22(2):E135-146. doi: 10.1001/amajethics.2020.135. Medicine and Society Mar 2020 Do Conflict of Interest Disclosures Facilitate Public Trust? Daylian M. Cain, PhD and Mohin Banker Even disclosed conflicts of interest can be dangerous in health care settings, but disclosure might not be the panacea many seem to take it to be. AMA J Ethics. 2020;22(3):E232-238. doi: 10.1001/amajethics.2020.232. Case and Commentary Feb 2016 How to Communicate Clearly about Brain Death and First-Person Consent to Donate Stuart J. Youngner, MD Despite clear donor consent, health professionals must communicate clearly about death to family members to avoid confusion. AMA J Ethics. 2016;18(2):108-114. doi: 10.1001/journalofethics.2017.18.2.ecas2-1602. Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345. Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353. Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361. Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368. Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022;24(5):E376-381. doi: 10.1001/amajethics.2022.376. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Medicine and Society Feb 2020 How Should Low- and Middle-Income Countries Motivate Equity in Cancer Prevention and Control? Justin M. List, MD, MAR, MSc and Jeremy M. O’Connor, MD, MHS Government and public-private coalitions have important roles in cancer surveillance in LMICs. AMA J Ethics. 2020;22(2):E147-155. doi: 10.1001/amajethics.2020.147.
Case and Commentary Feb 2020 When Is a Suboptimal Approach to Cancer Screening Better Than None? Ramy Sedhom, MD and Bishal Gyawali, MD, PhD Mortality rates for breast cancer are higher where treatments are unavailable and unaffordable. Though less effective, breast examination could be a good screening approach. AMA J Ethics. 2020;22(2):E93-101. doi: 10.1001/amajethics.2020.93.
Policy Forum Feb 2020 How Should Global Tobacco Control Efforts Be Prioritized to Protect Children in Resource-Poor Regions? Stella Aguinaga Bialous, DrPH and Yvette van der Eijk, PhD Tobacco and e-cigarette marketing is largely unrestricted in low- and middle-income countries, a violation of children’s rights. AMA J Ethics. 2020;22(2):E135-146. doi: 10.1001/amajethics.2020.135.
Medicine and Society Mar 2020 Do Conflict of Interest Disclosures Facilitate Public Trust? Daylian M. Cain, PhD and Mohin Banker Even disclosed conflicts of interest can be dangerous in health care settings, but disclosure might not be the panacea many seem to take it to be. AMA J Ethics. 2020;22(3):E232-238. doi: 10.1001/amajethics.2020.232.
Case and Commentary Feb 2016 How to Communicate Clearly about Brain Death and First-Person Consent to Donate Stuart J. Youngner, MD Despite clear donor consent, health professionals must communicate clearly about death to family members to avoid confusion. AMA J Ethics. 2016;18(2):108-114. doi: 10.1001/journalofethics.2017.18.2.ecas2-1602.
Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345.
Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353.
Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361.
Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368.
Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022;24(5):E376-381. doi: 10.1001/amajethics.2022.376.